Yahoo Web Search

  1. Ad
    related to Myriad Genetics
  1. Here's Why Myriad Genetics Is Soaring Today

    Motley Fool via Yahoo FinanceAug 01 17:32 PM

    Shares of Myriad Genetics (NASDAQ: MYGN) rose as much as 58.4% today, after the company published a filing with the U.S. Securities and Exchange Commission (SEC) disclosing that ...

  2. Why SunPower, Myriad Genetics, and Cirrus Logic Jumped Today

    Motley Fool via Yahoo FinanceAug 01 20:28 PM

    SunPower (NASDAQ: SPWR), Myriad Genetics (NASDAQ: MYGN), and Cirrus Logic (NASDAQ: CRUS) were among the top performers.

  3. CFO of Myriad Genetics Inc (30-Year Financial, Insider Trades) Richard Bryan Riggsbee (insider trades) sold 25,000 shares of MYGN on 08/01/2019 at an average price of $41.5 a share ...

  4. Shares added by 5.14% Apogee Enterprises Inc (APOG) - 140,491 shares, 5.34% of the total portfolio. Shares added by 5.61% Barrett Business Services Inc (BBSI) - 73,827 shares, 5.34% of the total ...

  5. Myriad Genetics Limps Into Fiscal 2020

    Motley Fool via Yahoo FinanceAug 15 15:25 PM

    Genetic testing company Myriad Genetics (NASDAQ: MYGN) has been tirelessly working on a short-term strategy to boost profitability called Elevate 2020, but investors are feeling ...

  6. Myriad Genetics Inc (MYGN) Q4 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceAug 14 1:23 AM

    Myriad Genetics Inc (NASDAQ: MYGN) Q4 2019 Earnings Call Aug 13, 2019, 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator ...

  7. Adjusted EPS also lagged the Zacks Consensus Estimate by 12.8%. br /> On a reported basis, loss per share was 6 cents, showing a sharp decline from the year-ago earnings of 20 cents a share.

  8. Myriad Genetics (NASDAQ:MYGN) Has A Pretty Healthy Balance Sheet

    Simply Wall St. via Yahoo FinanceAug 15 12:22 PM

    Importantly, Myriad Genetics, Inc. (NASDAQ:MYGN) does carry debt. Debt assists a business until the business has trouble paying it off, either with new capital or with free cash ...

  9. Myriad Genetics (NASDAQ: MYGN) stock soared earlier this month after the announcement that UnitedHealth Group will begin covering its GeneSight Psychotropic test beginning in October ...

  10. Myriad Genetics (MYGN) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.47 per share. This quarterly report represents an earnings ...

  1. Ads
    related to Myriad Genetics